INTERNATIONAL PATENT: ABL BIO INC., I-MAB BIOPHARMA US LIMITED FILES APPLICATION FOR "METHODS OF TREATING CANCER BY ADMINISTERING ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES"

GENEVA, March 25 -- ABL BIO INC. (16, Daewangpangyo-ro 712beon-gil,Bundang-gu, Seongnam-siGyeonggi-do 13488), I-MAB BIOPHARMA US LIMITED (2440 Research Boulevard, Suite 400Rockville, Maryland 20850) filed a patent application (PCT/KR2024/013952) for "METHODS OF TREATING CANCER BY ADMINISTERING ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES" on Sep 12, 2024. With publication no. WO/2025/058453, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Sangmi (16, Daewangpangyo-ro 712beon-gil,Bundang-gu, Seongnam-siGyeonggi-do 1348...